title: Pregnancy in an NTBC-treated patient with hereditary tyrosinemia type I.
authors.affiliation: Department of Pediatrics, Washington University School of Medicine, St Louis, MO.
authors.forename: Rachel
authors.initials: R
authors.lastname: Kassel
authors.forename: Laurie
authors.initials: L
authors.lastname: Sprietsma
authors.forename: David A
authors.initials: DA
authors.lastname: Rudnick
mesh_terms: D015111:4-Hydroxyphenylpyruvate Dioxygenase / Q000037:antagonists & inhibitors*; D000293:Adolescent; D003131:Combined Modality Therapy / Q000009:adverse effects; D000075202:Contraindications; D003512:Cyclohexanones / Q000009:adverse effects / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009579:Nitrobenzoates / Q000009:adverse effects / Q000627:therapeutic use*; D010649:Phenylalanine; D011247:Pregnancy; D011248:Pregnancy Complications / Q000178:diet therapy / Q000188:drug therapy*; D047929:Term Birth; D014443:Tyrosine; D020176:Tyrosinemias / Q000178:diet therapy / Q000188:drug therapy*
chemical_list: D003512:Cyclohexanones; D004791:Enzyme Inhibitors; D009579:Nitrobenzoates; D014443:Tyrosine; D010649:Phenylalanine; D015111:4-Hydroxyphenylpyruvate Dioxygenase; C077073:nitisinone